Kathryn E. Falberg

Kathryn E. Falberg

DirectoratTrade Desk· In proxies 2023–2025

Kathryn E. Falberg sits on 15 public boards.

Boards2

  • Trade DeskDirector · 8 yr on the boardIndependentCompensation (Chair)—Paid as an executive
  • Arcus BiosciencesDirector · 6 yr on the boardIndependentAudit, Compensation—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Trade DeskPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role -71%
  2. Arcus BiosciencesPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  3. Nuvation BioPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  4. Sio Gene Therapies Inc.Public company
    • Director? – PresentNo stock prices for these years
  5. Tricida, Inc.Public company · 4 yr
    • Director2018 – 2022 · 4 yrNo stock prices for these years
  6. Urogen Pharma Ltd.Public company · 7 yr
    • Director2015 – 2022 · 7 yrNo stock prices for these years
  7. Aimmune Therapeutics Inc.Public company · 5 yr
    • Director2015 – 2020 · 5 yrNo stock prices for these years
  8. Axovant Sciences Ltd.Public company · 1 yr
    • Director2017 – 2018 · 1 yrNo stock prices for these years
  9. BioMarin Pharmaceutical Inc.Public company · 1 yr
    • Director2016 – 2017 · 1 yrNo stock prices for these years
  10. aTyr Pharma, Inc.Public company · 3 yr
    • Director2014 – 2017 · 3 yrNo stock prices for these years
  11. Medivation, Inc.Public company · 3 yr
    • Director2013 – 2016 · 3 yrNo stock prices for these years
  12. Halozyme Therapeutics, Inc.Public company · 9 yr
    • Director2007 – 2016 · 9 yrNo stock prices for these years
  13. AdECN, Inc.Public company · 8 yr
    • Director2001 – 2009 · 8 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?